Diagnostic method for diseases by screening for hepcidin in...

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C530S350000, C530S387100, C435S975000

Reexamination Certificate

active

07411048

ABSTRACT:
The present invention concerns methods and kits for diagnosing a disease condition characterized by non-physiological levels of hepcidin, comprising obtaining a tissue or fluid sample from a subject; contacting the sample with an antibody or fragment thereof that specifically binds to a polypeptide corresponding to the mid-portion or C terminus of a hepcidin protein, and quantifying the hepcidin level using an assay based on binding of the antibody and the polypeptide; wherein the non-physiological level of hepcidin is indicative of the disease condition. The present invention also concerns diagnostic methods and kits for applications in genetic technological approaches, such as for overexpressing or downregulating hepcidin. The present invention further concerns therapeutic treatment of certain diseases by treatment of subjects with hepcidin and agonists or antagonists of hepcidin.

REFERENCES:
patent: 5420016 (1995-05-01), Boguslaski et al.
patent: 2002/0091247 (2002-07-01), Kaser et al.
patent: 2003/0027999 (2003-02-01), Rosen et al.
patent: 2004/0234527 (2004-11-01), Crisanti
patent: 2005/0037971 (2005-02-01), Nicolas et al.
patent: WO 0073454 (2000-12-01), None
patent: WO-02/098444 (2002-12-01), None
UniProtKB/Swiss-Prot entry Q5U9D2 HEPC CANFA, pp. 1-3, Jun. 28, 2006.
UniProtKB/Swiss-Prot entry P81172 HEPC Human, pp. 1-3, Jun. 28, 2006.
UniProtKB/Swiss-Prot entry Q8MJ80, HEPC Pig, pp. 1-3, Jun. 28, 2006.
UnitProtKB/Swiss-Prot entry Q9EQ21, HEPC Mouse, pp. 1-4, Jun. 28, 2006.
Wild, The Immunoassay Handbook, Stockton Press, 1994, p. 66.
Diamandis et al., Immunoassay, Academic Press, Chapter 11, The Avidin-Biotin System, pp. 237-255, 1996.
Wild et al., The Immunoassay Handbook, Chapter 2, Components, pp. 49-54, 1994.
Aden et al., (1979) Nature 282, 615-616.
Anderson et al., (2002) Biochem. Soc. Trans. 30, 724-726.
Andrews, N.C. (2000) Annu. Rev. Genomics Hum. Genet. 1, 75-98.
Beutler et al., (2001) Drug-Metab. Dispos. 29, 495-499.
Camasehella et al., (2000) Nat. Genet. 25, 14-15.
Collawn et al., (1990) Cell 63, 1061-1072.
Fleming et al., (2000) Proc. Natl. Acadi. Sci. USA 97, 2214-2219.
Fleming et al., (2002) Proc. Natl. Acad. Sci. USA 99, 10653-10658.
Frazer et al., (2002) Gastroenterology 123, 835-844.
Hunter et al., (2002) J. Biol. Chem., M205305200.
Kawabata et al., (1999) J. Biol. Chem. 274, 20826-20832.
Kawabata et al., (2000) J. Biol. Chem. 275, 16618-16625.
Krause et al., (2000) FEBS Lett. 480, 147-150.
Kulaksiz et al., (2002) Am. J. Pathol. 161, 655-664.
Kulaksiz et al., (2002) Proc. Natl. Acad. Sci. USA 99, 6796-6801.
Levy et al., (1999) Blood 94, 9-11.
Nicolas et al., (2001) Proc. Natl. Acad. Sci. USA 98, 8780-8785.
Nicolas et al., (2002) Proc. Natl. Acad. Sci. USA 99, 4396-4601.
Park et al., (2001) J. Biol. Chem. 276, 7806-7810.
Philpott, C.C. (2002) Hepatology 35, 993-1001.
Pigeon et al., (2001) J. Biol. Chem. 276, 7811-7819.
Rost et al., (1999) Hepatology 29, 814-821.
Santos et al., (1996) J. Exp. Med. 184, 1975-1985.
Schwartz et al., (1985) EMBO J. 4, 899-904.
Subramaniam et al., (2002) Cell Biochem. Biophys. 36, 235-239.
Zhou et al., (1998) Proc. Natl. Acad. Sci. USA 95, 2492-2497.
Brugnara, Carlo; “Iron Deficiency and Erythropoiesis: New Diagnostic Approaches,”; Clinical Chemistry 2003; vol. 49, No. 10, pp. 1573-1578.
Nemeth et al.; “Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein,”; Blood, Apr. 1, 2003; vol. 101, No. 7, pp. 2461-2463.
Swinkels et al.; “Hereditary hemochromatosis: genetic complexity and new diagnostic approaches,”; Clinical Chemistry 2006; vol. 52, No. 6, pp. 950-968.
Ashurst, P.R., Dennis, M.J., Analytical Methods of Food Authentication, 1998, p. 253, Blackie Academic and Professional, Thomson Science, London, UK.
Garcia-Beato, R., Melero, J.A., The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner, J. General Virology, 2000, pp. 917-927, vol. 81, UK.
Tang, R., et al. Epitope Mapping of Monoclonal Antibody to Integrin aLb2 Hybrid Domain Suggests Different Requirements of affinity States for Intercellular Adhesion Molecules (ICAM)-1 and ICAM-3 Binding, j. Biological Chemistry, Aug. 12, 2005, pp. 29208-29216, vol. 280, No. 32, The american Society for Biochemistry and Molecular Biology, USA.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic method for diseases by screening for hepcidin in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic method for diseases by screening for hepcidin in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method for diseases by screening for hepcidin in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4016434

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.